On-Target Editing
On-target validation examines whether the expected change occurred at the selected genomic locus. It may characterize substitution frequencies, indels, allele distributions and other relevant outcomes.
How can researchers determine whether
a genome editing experiment produced
the expected molecular change?
Validation examines more than a
targeted sequence. It may involve
editing frequency, off-target events,
cell-to-cell variation, large genomic
rearrangements and functional evidence.
Select an inspection mode. Each visualization represents a different scientific question, type of evidence and analytical limitation.
On-target validation examines whether the expected change occurred at the selected genomic locus. It may characterize substitution frequencies, indels, allele distributions and other relevant outcomes.
Editing systems can sometimes modify unintended sites. Researchers assess potential off-target changes using computational predictions, empirical site-nomination methods and sequencing of relevant candidate loci.
Sequencing can support allele characterization, variant detection and the assessment of editing outcomes. Interpretation depends on read coverage, alignment quality, assay design and potential detection biases.
An edited sample can contain multiple genotypes. Mosaicism is particularly relevant to developmental editing, while heterogeneous cultured populations may include unedited cells and distinct edited alleles.
Genome editing may be associated with large deletions, inversions, translocations or other complex genomic changes. Short targeted assays may fail to identify some of these events.
The intended DNA change does not necessarily establish the expected biological effect. Research may require gene-expression, protein-level and phenotypic measurements.
The interactive scanner is a scientific educational visualization, not an automated genomic analysis service. Its graphics contain no real samples, measurements, site predictions or clinical results.
DNA sequencing can confirm intended mutations and characterize certain unintended outcomes. However, sequencing results must be interpreted in the context of assay coverage, sampling, alignment and detection limits.
Can support detection and quantification of many small editing outcomes, provided that the assay captures relevant alleles.
Can help resolve larger insertions, deletions and complex sequence arrangements within the region surveyed.
Coverage, read quality, amplification bias, mapping ambiguity and analytical sensitivity can affect variant interpretation.
Large structural changes can affect genomic regions beyond a small targeted interval. Their detection may require specialized sequencing, cytogenetics or other orthogonal assays.
Figure 07. Conceptual structural variation. Inversion reverses the orientation of the affected segment; the illustrated B–C labels omit directional arrows for simplicity. X and Y indicate segments originating from another chromosome.
Deletion of a substantial DNA region can remove coding, regulatory or other genomic sequences surrounding the intended editing site.
A chromosomal segment may be rejoined in the opposite orientation, potentially affecting gene structure or regulatory relationships.
DNA segments from different chromosomes can become incorrectly joined, particularly when multiple DNA breaks are present.
Gains or losses of genomic material may alter gene dosage or indicate broader structural instability.
Figure 08. A schematic mixture of unedited cells (WT) and two hypothetical edited genotypes (E1 and E2). The cell counts are illustrative, not measurements.
Editing outcomes may differ between individual cells. A population-level result can therefore combine distinct edited and unedited genotypes.
When editing occurs during development, mosaicism can describe genetically distinct cell populations derived from the same organism. In cultured systems, the related concern is often population heterogeneity.
A DNA sequence change does not necessarily mean that gene expression, protein activity or cellular behavior changed in the expected way.
Establish the intended molecular change and characterize relevant unintended outcomes.
Examine relevant transcript abundance, expression patterns or RNA processing.
Assess protein abundance, activity, localization or another appropriate molecular phenotype.
Connect genetic changes with a relevant biological effect using suitable experimental controls.
No single assay can detect every possible editing outcome. An appropriate validation strategy combines methods according to the scientific question, editing system, sample and required detection sensitivity.
Targeted sequencing and other sequence-level methods can assess substitutions and many small indels within the sampled region.
Editor-appropriate site nomination, computational analysis and targeted confirmation can help investigate specificity.
Long-range sequencing, long reads, copy-number analysis or structural variant methods may detect changes not captured by short amplicons.
Bulk allele quantification, single-cell analysis and clonal methods provide complementary views of heterogeneous samples.
Appropriate gene-expression, protein and functional assays support interpretation of biological effects in relevant models.
Controls, appropriate replication, transparent sample documentation, data quality assessment and clearly reported limitations strengthen scientific conclusions.
These resources discuss genome editing specificity, structural variants, cellular heterogeneity, sequencing approaches and validation strategies.
The diagrams on this page are original educational illustrations and do not represent patient data, real experiments or measured assay performance.
EditGene provides scientific educational content only. This page does not perform actual genomic analysis, certify the safety of an edited sample or establish clinical suitability. The appropriate methods and acceptance criteria depend on the research or regulated context.